Empower microfluidics technology to formulate high quality DDS medicines
Scale up into Microfluidic mass-production
enParticle is a biotech frontier in technologies, and formulation services for the development of DDS pharmaceuticals and cosmetics including LNP, liposomes and polymeric vesicles.
FORMULATION MACHINES
FORMULATION SERVICE
UPCOMING
EVENTS
enParticle is a biotech frontier in technologies, and formulation services for the development of DDS pharmaceuticals and cosmetics including LNP, liposomes and polymeric vesicles.
FORMULATION MACHINES
FORMULATION SERVICE
UPCOMING
EVENTS
Microfluidics mass production for
high-quality pharmaceuticals
Enter microfluidics, an interdisciplinary domain where engineering, chemistry, and biology converge to redefine pharmaceutical production. At its core, microfluidics enables the precise manipulation of fluids at the microscale, allowing for the creation of pharmaceuticals with unprecedented precision, uniformity, and efficiency.
per minute production
cut down production time
microfluidics innovation
We have achieved mass production innovation of up to 5L/m in the field of microfluidics.
high quality formulation
EnParticle has technology that does not yield in terms of quality such as size, uniformity, and chemical homogeneity.
continuous production
Core technology for continuous drug production that overcomes existing batch production of drugs.
Microfluidics Innovation
Microfluidic Formulation Machines are the primary focus of our company, which is called CMO of DDS Pharmaceuticals.
Machine business
Our equipment is meticulously crafted to deliver exceptional performance, enabling seamless particle production and research advancements.
CDMO
We are committed to delivering tailored solutions that meet unique requirements, accelerate development, and enhance quality.
Microfluidics Innovation
Microfluidic Formulation Machines are the primary focus of our company, which is called CMO of DDS Pharmaceuticals.
Machine business
Our equipment is meticulously crafted to deliver exceptional performance, enabling seamless particle production and research advancements.
CMO business
We are committed to delivering tailored solutions that meet unique requirements, accelerate development, and enhance quality.
World-class particle mass production technology
The enCell device, which we have successfully developed and brought to market,
utilizes advanced technology to facilitate the production of mRNA vaccines.
- beauty (cosmetics)
- electronics (semiconductor)
- bio technology
- medicine
faster production
uniformity
control rate
cost savings
CMO Business
We have the optimal production process technology for uniform size, high yield and high quality functional DDS particle formulations applied with microfluidic technology.
size control
uniformity control
encapsulation control
property control
CMO Business
We have the optimal production process technology for uniform size, high yield and high quality functional DDS particle formulations applied with microfluidic technology.
size control
uniformity control
encapsulation control
property control
enCell Master
This versatile microfluidic platform serves as a cornerstone for researchers, offering precise control over particle generation for a...
enCell Pharm
Elevating research to clinical scale, enCELL Pharm operates at a flow rate of 100 mL/min. Designed to meet the stringent demands...
enCell Scale-Up
enCELL Scale-up produces highly functionalized particles in the wide fields. From pharmaceuticals to cosmetic, enCELL...
Partner with Us for Microfluidics Excellence
Contact us today to explore how our microfluidics solutions can empower your pharmaceutical endeavors. Let’s shape the future of medicine together.
EnCell is trying to develop a clear and comprehensive sustainability strategy.
This strategy should outline the company's commitment to environmental stewardship, social responsibility, and economic viability. Our company's efforts, setting priorities, and driving continuous improvement towards a more sustainable microfluidics solution company.